Medication Monitoring with Urine Drug Testing in Obstetrics / Gynecology (OB/GYN) safeguards the health of mother and child
Medication and substance use during pregnancy can have major health implications for expectant mothers and newborns. Neonatal abstinence syndrome (NAS) has nearly tripled in the past decade, and newborns diagnosed with NAS are more likely to have trouble breathing, low birth weight, feeding difficulties, and seizures 1,2. When used in conjunction with other universal screening tools, urine drug testing (UDT) may help clinicians proactively assess medication use, misuse and addiction that can result in harm for the mother and the developing fetus. Test results offer an opportunity for patient assessment and education regarding risk for mother and baby.
Millennium UDTSM in OB/GYN practice may provide critical information on a patient’s medication and substance use, helping clinicians
- Support healthy outcomes for pregnant women and their babies
- Monitor and support decisions about medication therapy, particularly controlled substances
- Identify recent use of prescription medications, non-prescribed medications and illicit substances
- Detect medications that may result in a drug-drug interaction
- Advocate for and communicate with patients about individual treatment plans
- Identify possible illicit drug or medication abuse, misuse or diversion
Contact us to learn more about utilizing Millennium UDT in OB/GYN practice
Learn more about clinical guidelines and peer reviewed articles for UDT in OB/GYN practice3
Request Information on Millennium UDT
Health Care Providers, use the form below to learn more about quantitative urine drug testing with Millennium UDT.